Return to Article Details
EFFECTS OF TOCILIZUMAB AND SYSTEMIC CORTICOSTEROIDS IN PATIENTS WITH CARDIOVASCULAR DISEASE ON CLINICAL OUTCOMES IN COVID-19
Download
Download PDF